ciglitazone has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (91.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dulak, J; Huk, I; Jozkowicz, A; Nanobashvili, J; Nigisch, A; Prager, M; Weigel, G; Winter, B | 1 |
| Dembinska-Kiec, A; Dulak, J; Jozkowicz, A; Piatkowska, E; Placha, W | 1 |
| Feinstein, D; Grommes, C; Heneka, MT; Klockgether, T; Koenigsknecht, J; Kraus, JA; Landreth, G; Schlegel, U; Zander, T | 1 |
| Frauwirth, KA; Lazar, MA; Rangwala, SM; Thompson, CB; Wang, YL | 1 |
| Greenberg, AS; Mathys, JM; Rabbi, MF; Skolnik, PR | 1 |
| Burghardt, R; Qin, C; Safe, S; Smith, R; Stewart, J; Wormke, M | 1 |
| Curry, TE; Komar, CM | 1 |
| Dembińska-Kieć, A; Gil, D; Laidler, P; Placha, W | 1 |
| Abu-Ghazaleh, R; Avis, I; Martínez, A; Mayburd, A; Mulshine, JL; Ondrey, F; Tauler, J; Zudaire, E | 1 |
| Chen, N; Liu, F; Wang, WM | 1 |
| Komar, C; Tinfo, N | 1 |
| Abu Ghazallah, R; Gaffney, PM; Harris, G; Miller, WA; Ondrey, FG; Wright, SK; Wuertz, BR | 1 |
12 other study(ies) available for ciglitazone and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner.
Topics: Cell Line; Cell Survival; Electrophoretic Mobility Shift Assay; Endothelium, Vascular; Humans; Interleukin-8; Ligands; NF-kappa B; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Up-Regulation | 2001 |
Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages.
Topics: Animals; Antineoplastic Agents; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Hypoglycemic Agents; Interleukin-1; Ligands; Lipopolysaccharides; Lymphokines; Macrophages; Mice; Muscle, Smooth; Promoter Regions, Genetic; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Cadherins; Carrier Proteins; Cell Division; Cell Survival; DNA Fragmentation; Drug Evaluation, Preclinical; Glioma; Humans; Nuclear Proteins; Oligonucleotides, Antisense; Prostaglandin D2; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 2002 |
Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
Topics: Animals; Cell Death; Cell Survival; Cells, Cultured; Humans; Hypoglycemic Agents; Interleukin-3; Lymphocyte Activation; Membrane Potentials; Mice; Mice, Inbred C57BL; Mitochondria; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; T-Lymphocytes; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Up-Regulation | 2002 |
Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Chromans; Fenofibrate; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages, Alveolar; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Necrosis Factor-alpha; Virus Replication | 2002 |
Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Cyclin D1; Cysteine Endopeptidases; Down-Regulation; Estrogen Receptor alpha; G1 Phase; Humans; Multienzyme Complexes; Prostaglandin D2; Proteasome Endopeptidase Complex; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; RNA, Messenger; S Phase; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Ubiquitin | 2003 |
Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary.
Topics: Animals; Apoptosis; Cells, Cultured; Cholesterol Side-Chain Cleavage Enzyme; Cytochrome P-450 Enzyme System; Female; Follicle Stimulating Hormone; Granulosa Cells; Hypoglycemic Agents; In Situ Hybridization; Ovary; Prostaglandin D2; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazolidinediones; Transcription Factors | 2003 |
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Ligands; Luciferases; Melanoma; Microscopy, Fluorescence; Promoter Regions, Genetic; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Time Factors; Transcription Factors | 2003 |
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Topics: Acetophenones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arachidonic Acid; Caspases; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Indoles; Isotretinoin; Ligands; Lung Neoplasms; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Pyrimidines; Retinoid X Receptor alpha; RNA, Messenger; Tetrazoles; Thiazolidinediones | 2005 |
[Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Topics: Animals; Blotting, Far-Western; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Kidney; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Potential role for peroxisome proliferator-activated receptor gamma in regulating luteal lifespan in the rat.
Topics: Anilides; Animals; Cell Nucleus; Cholesterol Side-Chain Cleavage Enzyme; Corpus Luteum; Corpus Luteum Maintenance; Female; Immunohistochemistry; In Situ Hybridization; PPAR gamma; Pregnancy; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Tissue Culture Techniques | 2007 |
Functional activation of PPARγ in human upper aerodigestive cancer cell lines.
Topics: Antineoplastic Agents; Arachidonic Acids; Cell Line; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lipid Metabolism; Mouth; Mouth Neoplasms; PPAR gamma; Prostaglandin D2; Thiazolidinediones | 2017 |